ACUTE GRAFT VERSUS HOST DISEASE
Clinical trials for ACUTE GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new ACUTE GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for ACUTE GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills tested to stop deadly transplant complication
Disease control OngoingThis study is testing whether taking capsules containing processed, healthy stool (fecal microbiota) can prevent severe graft-versus-host disease (GVHD) in adults who have received a bone marrow transplant. GVHD is a serious and common complication where the donor's immune cells …
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
Could the clock hold the key to safer transplants?
Disease control OngoingThis study is testing whether the time of day a patient receives donor stem cells affects their risk of developing a serious complication called acute graft-versus-host disease (aGVHD). It involves 198 patients with blood cancers who are getting a stem cell transplant. Researcher…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Friendly bacteria vs. transplant danger: can a probiotic shield kids?
Prevention OngoingThis study is testing whether a specific probiotic (Lactobacillus plantarum) can prevent a serious complication called acute graft-versus-host disease (GvHD) in children, teens, and young adults getting a stem cell transplant from a donor for cancers like leukemia or lymphoma. Ab…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC
-
New treatment aims to stop dangerous transplant complication
Prevention OngoingThis study is testing whether a protein called Alpha-1 Antitrypsin can prevent graft-versus-host disease (GVHD) in patients receiving stem cell transplants for blood cancers. GVHD is a serious complication where the donor's immune cells attack the patient's body. The trial involv…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE2, PHASE3 • Sponsor: CSL Behring • Aim: Prevention
Last updated Mar 17, 2026 12:55 UTC
-
Scientists probe Skin's immune sentries in transplant complication
Knowledge-focused OngoingThis study aims to understand the role of specific immune cells, called dendritic cells, in the development of skin graft-versus-host disease (GVHD) after a bone marrow transplant. Researchers will collect and analyze small skin samples from 22 adult patients who have either acut…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC